0001140361-24-037709.txt : 20240816
0001140361-24-037709.hdr.sgml : 20240816
20240816210134
ACCESSION NUMBER: 0001140361-24-037709
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240814
FILED AS OF DATE: 20240816
DATE AS OF CHANGE: 20240816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ma Songjiang
CENTRAL INDEX KEY: 0001985547
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51173
FILM NUMBER: 241218070
MAIL ADDRESS:
STREET 1: 12730 HIGH BLUFF DRIVE
STREET 2: SUITE 250
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GYRE THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001124105
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 562020050
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (619) 949-3681
MAIL ADDRESS:
STREET 1: 12770 HIGH BLUFF DRIVE, SUITE 150
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST BIOSCIENCES, INC.
DATE OF NAME CHANGE: 20150820
FORMER COMPANY:
FORMER CONFORMED NAME: TARGACEPT INC
DATE OF NAME CHANGE: 20000919
4
1
form4.xml
FORM 4
X0508
4
2024-08-14
0001124105
GYRE THERAPEUTICS, INC.
GYRE
0001985547
Ma Songjiang
C/O GYRE THERAPEUTICS, INC.
12770 HIGH BLUFF DRIVE, SUITE 150
SAN DIEGO
CA
92130
true
true
President
false
Stock Option (Right to Buy)
9.98
2024-08-14
4
A
0
26000
0
A
2034-08-14
Common Stock
26000
26000
D
This option represents a right to purchase a total of 26,000 shares of the Issuer's common stock, which will vest in 12 equal monthly installments through August 14, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date.
/s/ Ruoyu Chen, as attorney-in-fact for Songjiang Ma
2024-08-16